Free Trial

First Trust NYSE Arca Biotechnology Index Fund (FBT) Holdings List

First Trust NYSE Arca Biotechnology Index Fund logo
$208.48 +0.23 (+0.11%)
Closing price 04:10 PM Eastern
Extended Trading
$208.45 -0.03 (-0.02%)
As of 05:41 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

What stocks does FBT hold?

The First Trust NYSE Arca Biotechnology Index Fund (FBT) top stock holdings include BioNTech, Arrowhead Pharmaceuticals, and ADMA Biologics. The top 25 FBT holdings ordered by weight make up 84.35% of the total fund. FBT is an equity fund in the sector category that invests in publicly traded companies, focused on health care strategies within the North America region. This page includes a complete FBT stock holdings list ranked by weight, along with a full breakdown of sector, geographic, industry, and currency exposure.

Top 25 FBT Holdings

RankCompanyCurrent PriceWeightShares Held
1
BioNTech SE Sponsored ADR stock logo
BNTX
BioNTech
$95.48
-3.9%
3.65%791,534
2
Arrowhead Pharmaceuticals, Inc. stock logo
ARWR
Arrowhead Pharmaceuticals
$74.95
-1.9%
3.64%1,160,446
3
ADMA Biologics Inc stock logo
ADMA
ADMA Biologics
$10.24
-0.7%
3.62%7,792,132
4
Corcept Therapeutics Incorporated stock logo
CORT
Corcept Therapeutics
$51.37
-0.5%
3.57%1,803,662
5
Biogen Inc. stock logo
BIIB
Biogen
$189.18
+1.1%
3.53%437,021
6
Veracyte, Inc. stock logo
VCYT
Veracyte
$33.00
-1.4%
3.48%2,431,376
7
Illumina, Inc. stock logo
ILMN
Illumina
$139.07
-0.2%
3.46%625,085
8
Natera, Inc. stock logo
NTRA
Natera
$207.01
-2.2%
3.46%391,605
9
Krystal Biotech, Inc. stock logo
KRYS
Krystal Biotech
$284.52
-0.8%
3.42%291,859
10
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
$8.86
-1.6%
3.41%9,829,840
11
Exelixis, Inc. stock logo
EXEL
Exelixis
$44.43
+0.6%
3.40%1,707,510
12
Bruker Corporation stock logo
BRKR
Bruker
$38.04
+4.5%
3.39%2,010,946
13
Bio-Techne Corp stock logo
TECH
Bio-Techne
$56.67
+3.5%
3.39%1,361,028
14
Axsome Therapeutics, Inc. stock logo
AXSM
Axsome Therapeutics
$222.94
-0.3%
3.36%424,409
15
Repligen Corporation stock logo
RGEN
Repligen
$125.69
+6.3%
3.33%629,404
16
Neurocrine Biosciences, Inc. stock logo
NBIX
Neurocrine Biosciences
$135.18
+0.8%
3.27%586,481
17
Alkermes plc stock logo
ALKS
Alkermes
$36.26
+6.1%
3.25%2,265,931
18
BeOne Medicines Ltd. - Sponsored ADR stock logo
ONC
BeOne Medicines
$297.38
+0.1%
3.24%244,111
19
Halozyme Therapeutics, Inc. stock logo
HALO
Halozyme Therapeutics
$65.89
+2.0%
3.24%1,114,590
20
Incyte Corporation stock logo
INCY
Incyte
$97.50
+0.4%
3.23%786,837
21
United Therapeutics Corporation stock logo
UTHR
United Therapeutics
$572.94
-1.4%
3.22%132,215
22
Vertex Pharmaceuticals Incorporated stock logo
VRTX
Vertex Pharmaceuticals
$424.31
-1.3%
3.22%173,268
23
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$702.45
-1.0%
3.20%100,941
24
BioMarin Pharmaceutical Inc. stock logo
BMRN
BioMarin Pharmaceutical
$53.26
-4.0%
3.19%1,386,236
25
argenex SE stock logo
ARGX
argenex
$794.92
-2.0%
3.18%94,531

FBT Geographic Exposure

FBT's largest geographic exposure is United States at 96.7%, followed by Ireland at 3.3%.

  • United States
    96.7%
  • Ireland
    3.3%

FBT Currency Exposure

FBT is exclusively exposed to USD.

  • USD
    100.0%

FBT Sector Exposure

FBT's largest sector exposure is Health Care at 100.0%.

  • Health Care
    100.0%

FBT Industry Exposure

FBT's largest industry exposure is Biotechnology at 79.3%, followed by Health Care Equipment & Supplies at 13.4%.

  • Biotechnology
    79.3%
  • Health Care Equipment & Supplies
    13.4%
  • Health Care Providers & Services
    7.3%

FBT Sub-Industry Exposure

FBT's largest sub-industry exposure is Biotechnology at 72.0%, followed by Life Sciences Tools & Services at 13.4%.

  • Biotechnology
    72.0%
  • Life Sciences Tools & Services
    13.4%
  • Health Care Services
    7.3%
  • Pharmaceuticals
    4.0%

Related Companies and Tools


This page (NYSEARCA:FBT) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners